Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
In: Arteriosclerosis, Thrombosis & Vascular Biology, Jg. 41 (2021-02-01), Heft 2, S. 962-975
academicJournal
Zugriff:
Titel: |
Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
|
---|---|
Autor/in / Beteiligte Person: | Taskinen, Marja-Riitta ; Björnson, Elias ; Kahri, Juhani ; Söderlund, Sanni ; Matikainen, Niina ; Porthan, Kimmo ; Ainola, Mari ; Hakkarainen, Antti ; Lundbom, Nina ; Fermanelli, Valentina ; Fuchs, Johannes ; Thorsell, Annika ; Kronenberg, Florian ; Andersson, Linda ; Adiels, Martin ; Packard, Chris J. ; Borén, Jan |
Zeitschrift: | Arteriosclerosis, Thrombosis & Vascular Biology, Jg. 41 (2021-02-01), Heft 2, S. 962-975 |
Veröffentlichung: | 2021 |
Medientyp: | academicJournal |
ISSN: | 1079-5642 (print) |
DOI: | 10.1161/ATVBAHA.120.315446 |
Sonstiges: |
|